Literature DB >> 30961836

Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction.

Peter Valent1, Cem Akin2.   

Abstract

Mast cell activation syndrome (MCAS) is a rare condition defined by a severe systemic reaction to mast cell (MC)-derived mediators. Most cases present with clinical signs of anaphylaxis, and some have an underlying IgE-dependent allergy. A primary MC disease (mastocytosis) may also be detected. Severe recurrent MCAS episodes requiring intensive care or even resuscitation are typically found in patients who suffer from both mastocytosis and allergy against certain triggers, such as hymenoptera venom components. A less severe form and a local form of MC activation (MCA) also exist. For these patients, diagnostic criteria are lacking. Moreover, a number of different, unrelated, conditions with overlapping symptoms may be confused with MCAS. As a result, many patients believe that they are suffering from MCAS but have in fact a less severe form of MCA or another underlying disease. In the current article, we review the potential differential diagnoses of MCA and MCAS and discuss available diagnostic criteria and diagnostic tools. These criteria and assays may be useful in daily practice and help avoid unnecessary referrals and unjustified fears in patients.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergy; Anaphylaxis; Mast cell activation; Mast cells; Tryptase

Year:  2019        PMID: 30961836     DOI: 10.1016/j.jaip.2018.11.045

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  8 in total

Review 1.  Evaluation and Classification of Mast Cell Disorders: A Difficult to Manage Pathology in Clinical Practice.

Authors:  Polliana Mihaela Leru
Journal:  Cureus       Date:  2022-02-13

2.  The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.

Authors:  Gerard E Mullin; William D Chey; Sheila E Crowe
Journal:  Gastroenterology       Date:  2020-03-26       Impact factor: 22.682

Review 3.  Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.

Authors:  Luísa Leite Barros; Alberto Queiroz Farias; Ali Rezaie
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

4.  The management of adult patients with severe chronic small intestinal dysmotility.

Authors:  Jeremy M D Nightingale; Peter Paine; John McLaughlin; Anton Emmanuel; Joanne E Martin; Simon Lal
Journal:  Gut       Date:  2020-08-21       Impact factor: 23.059

Review 5.  Adult-onset mast cell activation syndrome following scombroid poisoning: a case report and review of the literature.

Authors:  Isabelle Brock; Nicole Eng; Anne Maitland
Journal:  J Med Case Rep       Date:  2021-12-18

Review 6.  Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.

Authors:  Clayton Webster Jackson; Cristina Marie Pratt; Chase Preston Rupprecht; Debendra Pattanaik; Guha Krishnaswamy
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

7.  Inhibition of Complex I of the Respiratory Chain, but Not Complex III, Attenuates Degranulation and Cytokine Secretion in Human Skin Mast Cells.

Authors:  Thomas Buttgereit; Moritz Pfeiffenberger; Stefan Frischbutter; Pierre-Louis Krauß; Yuling Chen; Marcus Maurer; Frank Buttgereit; Timo Gaber
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

8.  Comparing histamine intolerance and non-clonal mast cell activation syndrome.

Authors:  Nevio Cimolai
Journal:  Intest Res       Date:  2020-01-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.